Proceedings: Effects of antiphlogistic drugs on the adenyl cyclase system of fibroblasts.
D000067956:Adenylyl Cyclase Inhibitors; D000700:Analgesics / Q000494:pharmacology*; D000818:Animals; D002478:Cells, Cultured; D000242:Cyclic AMP / Q000378:metabolism; D005347:Fibroblasts / Q000201:enzymology; D005439:Flufenamic Acid / Q000494:pharmacology; D006025:Glycosaminoglycans / Q000378:metabolism; D007213:Indomethacin / Q000494:pharmacology; D008528:Mefenamic Acid / Q000494:pharmacology; D051379:Mice; D010653:Phenylbutazone / Q000494:pharmacology; D011241:Prednisone / Q000494:pharmacology; D047428:Protein Kinase Inhibitors; D012459:Salicylates / Q000494:pharmacology
D000067956:Adenylyl Cyclase Inhibitors; D000700:Analgesics; D006025:Glycosaminoglycans; D047428:Protein Kinase Inhibitors; D012459:Salicylates; D008528:Mefenamic Acid; D005439:Flufenamic Acid; D000242:Cyclic AMP; D010653:Phenylbutazone; D011241:Prednisone; D007213:Indomethacin